Amicus Therapeutics

2 followers

‌

Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.

Org chart

Bradley L. Campbell
President & CEO

Bradley L. Campbell

Collapse
Jayne C. Gershkowitz
Chief Patient Advocate
Jeffrey P. Castelli
Chief Portfolio Officer and Head of Gene Therapy
Patrik Florencio
Senior Vice President, Global Chief Compliance & Risk Officer
Jill Weimer
Chief Science Officer
Pat Osullivan
Chief Technical Operations Officer
Sam Pierre-Louis
SVP Chief Information Officer
Jordan Masanoff
Senior Director, Business Development & Portfolio Planning
Heather Ramirez
Vice President, Legal
Megan Bilson
Sr. Vice President, Global HR & Talent Executive
Mike Keavany
President, US Business And Head, Global Marketing